BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8838116)

  • 1. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
    De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
    Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell rich B-cell non-Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease.
    Stringfellow HF; Wells S
    Histopathology; 1996 Sep; 29(3):292-3. PubMed ID: 8884363
    [No Abstract]   [Full Text] [Related]  

  • 4. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
    Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
    Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.
    Chittal SM; Brousset P; Voigt JJ; Delsol G
    Histopathology; 1991 Sep; 19(3):211-20. PubMed ID: 1655614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
    Schmidt U; Metz KA; Leder LD
    Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features.
    Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
    Histopathology; 2002 Jan; 40(1):31-45. PubMed ID: 11903596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma.
    Algara P; Martinez P; Sanchez L; Villuendas R; Orradre JL; Oliva H; Piris MA
    Histopathology; 1991 Jul; 19(1):69-75. PubMed ID: 1916688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distinction of Hodgkin's disease from B cell lymphoma.
    Warnke RA
    Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
    Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
    Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
    Hartmann S; Cogliatti S; Hansmann ML
    Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
    Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
    Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study.
    Nicholas DS; Harris S; Wright DH
    Histopathology; 1990 Feb; 16(2):157-65. PubMed ID: 2323737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
    Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
    Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.